Welcome to PharmaEd

PharmaEd is a specialist medical education company, focusing on the disease related information needs of professionals involved in the clinical development of new medicines.

We can help meet your needs using a blend of live and virtual events, activities and resources.

»Read More About Us...
Creating Enduring Learning Materials

Creating Enduring Learning Materials

In traditional face-to-face training events,the deliverable was the experience.

Now, that is no longer enough.

People, processes and products have to work smarter, harder, and deliver more.That is why our training activities roll out a range of enduring learning materials.

» Read More...
First Choice for Learning Professionals

First Choice for Learning Professionals

Managing learning and development in the fast-moving world of drug development is difficult.

Compounds, indications and priorities change - and the people change too.

The solution to good disease area training is a stream of activities that happen over extended periods of time.   

» Read More...

In-House Bespoke Training

In-House Bespoke Training

Bespoke training programs to meet your global teams’ information needs
Choose from:

  • Traditional classroom sessions
  • Clinical seminars with patients and physicians
  • Clinical experience programs in specialist centers 
  • Virtual sessions on PharmaEd’s webinar platform 
  • E-Learning modules
     
» Read More

Webinars with Global Experts

Webinars with Global Experts

Key Opinion Leaders in the field present reviews of conditions, including their current and emerging new therapies.

 Webinars available as:

  • Live Events
  • On demand re-transmissions
  • In house bespoke events with KOLs
  • In house breifing events with internal experts
  • Pre-congress commercial briefings
» Read More

Sample a Complimentary Webinar

Sample a Complimentary Webinar

Sample a PharmaEd webinar on Acute Myeloid Leukemia with Eric J Feldman MD, an expert on Haemotological Malignancies from Weill Medical College of Cornell University, New York.

Dr Feldman addresses the current understanding of the disease, current management strategies including risk stratification and promising future therapies.

» Read More